EU warehouse review
Out of stock
Tirzepatide 10 mg — Research use only
Lyophilized Tirzepatide peptide supplied for laboratory research use only.
€39.10 per vial€39.10
Research material only. Not for human or veterinary use. No instructions for administration, dosing, or therapeutic use are provided.
CAS2023788-19-2
Variant10 mg
Current-lot recordsRequest availability
FormLyophilized powder
StorageFollow lot-specific label and documentation
AvailabilityOut of stock
COA on requestCurrent lot documentation is confirmed during order review.
Tracked EU shippingShipping cost and destination eligibility are reviewed before payment.
Payment after reviewPayment instructions are sent only after availability is confirmed.
Next working day dispatchOrders are prepared for the next working day after payment is received.
Dual incretin profile
Tirzepatide research context
Tirzepatide is a dual GIP and GLP-1 receptor agonist reference compound. On PeptidesLab it works as the comparison point for semaglutide-style GLP-1 research and retatrutide-style triple agonist research.
Is tirzepatide the same as retatrutide?
No. Retatrutide includes a glucagon receptor pathway that tirzepatide does not.
Why does vial strength matter?
Different vial strengths can create ordering and recordkeeping errors if the lot, variant and protocol notes are not matched.
Related reading
Useful guides before ordering Tirzepatide
Internal guide links help customers compare options, understand documentation and avoid relying on a single catalog page.
Product specifications
| CAS number | 2023788-19-2 |
|---|---|
| Current-lot documentation | Request availability before ordering |
| Form | Lyophilized powder |
| Storage | Follow lot-specific label and documentation |
Related catalog
You may also need